Richmond Pharmacology is delighted to announce the promotion of Samarjit Singh into the position of Director of Clinical Operations.

Samarjit has been part of the Richmond Pharmacology team for more than 16 years, during which he held several positions, including his most recent as Head of Scheduling.

In his new role, Samarjit will bring his years of industry experience and knowledge to drive best practice in (non-medical) clinical operations execution across the company, setting strategic guidance for the clinical operations teams and providing operational direction for the delivery of clinical trials undertaken at Richmond Pharmacology.

The position of Director of Clinical Operations has been developed to reflect the planned growth strategy of Richmond Pharmacology.

On his promotion, Samarjit said: “I’m excited about the opportunity to elevate clinical operations to the next level within Richmond Pharmacology.”

Richmond Pharmacology is a full-service clinical research organisation based in London, UK. Founded in 2001, Richmond Pharmacology is led by its founding directors Dr Jorg Taubel, CEO and Dr Ulrike Lorch, whose experience has been gained in more than 500 clinical trials.

Latest news

Richmond Pharmacology appoints Sandra Johnson as Director of Commercial Project Management

September 19, 2022
We are delighted to announce that Sandra Johnson will join Richmond Pharmacology as its new Director for Commercial Project Management
Read more

How telemonitoring can revolutionise the way we treat patients – Tom York

November 17, 2022
Richmond Pharmacology always searches for the most innovative processes to improve clinical trials and the patients’ experiences and treatments.
Read more


JPW2022 (Japan Basic and Clinical Pharmacology Week 2022)

30 November – 3 December 2022
This event will be the 96th Annual Meeting of the Japanese Pharmacological Society and the 43rd Annual Meeting of the Japanese Society of Clinical Pharmacology. 
View event